Multitarget FISH analysis in the diagnosis of lung cancer

American Journal of Clinical Pathology

Volumn 123, Issue 4, 2005, Pages 516-523

  Bubendorf, Lukas ^a   Müller, Phaedra ^a,b   Joos, Ladina ^b   Grilli, Bruno ^a   Vogel, Sandrine ^a   Herzog, Michelle ^a   Barascud, Audrey ^a   Feichter, Georg ^a   Dalquen, Peter ^a   Tamm, Michael ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Bronchial; Chromosomes; Cytology; Field cancerization; FISH; Fluorescence in situ hybridization; Lung cancer; Multiprobe

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING; TRACHEOBRONCHIAL TOILET;

EID: 20144363972     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/F5ADJUWVD2WFL8J5     Document Type: Article

References (33)

1. Spiro SG, Porter JC. Lung cancer: where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med. 2002;166:1166-1196.
2. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123(1 suppl):21S-49S.
3. Jemal A, Travis WD, Tarone RE, et al. Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer. 2003;105:101-107.
4. Tan BB, Flaherty KR, Kazerooni EA, et al. The solitary pulmonary nodule. Chest. 2003;123(1 suppl):89S-96S.
5. Rivera MP, Detterbeck F, Mehta AC. Diagnosis of lung cancer: the guidelines. Chest. 2003;123(1 suppl):129S-136S.
6. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest. 2003;123(1 suppl):115S-128S.
7. Steffee CH, Segletes LA, Geisinger KR. Changing cytologic and histologic utilization patterns in the diagnosis of 515 primary lung malignancies. Cancer. 1997;81:105-115.
8. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 2002;3:461-469.
9. Schwendel A, Langreck H, Reichel M, et al. Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations. Int J Cancer. 1997;74:86-93.
10. Petersen I, Bujard M, Petersen S, et al. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res. 1997;57:2331-2335.
11. Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene. 2002;21:6877-6883.
12. Jiang F, Katz RL. Use of interphase fluorescence in situ hybridization as a powerful diagnostic tool in cytology. Diagn Mol Pathol. 2002;11:47-57.
13. Sokolova IA, Bubendorf L, O'Hare A, et al. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer. 2002;96:306-315.
14. Sokolova IA, Halling KC, Jenkins RB, et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn. 2000;2:116-123.
15. Bubendorf L, Grilli B, Sauter G, et al. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol. 2001;116:79-86.
16. Albertson DG, Collins C, McCormick F, et al. Chromosome aberrations in solid tumors. Nat Genet. 2003;34:369-376.
17. Schenk T, Ackermann J, Brunner C, et al. Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients. Chest. 1997;111:1691-1696.
18. Zojer N, Dekan G, Ackermann J, et al. Aneuploidy of chromosome 7 can be detected in invasive lung cancer and associated premalignant lesions of the lung by fluorescence in situ hybridisation. Lung Cancer. 2000;28:225-235.
19. Santos Romeo M, Sokolova IA, Morrison LE, et al. Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization. J Mol Diagn. 2003;5:103-112.
20. Varella-Garcia M, Kittelson J, Schulte AP, et al. Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. Cancer Detect Prev. 2004;28:244-251.
21. Smith AL, Hung J, Walker L, et al. Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients. Br J Cancer. 1996;73:203-209.
22. Inage Y, Ogata T, Yamamoto T, et al. Topographical analysis of p53 expression and DNA ploidy in early bronchial squamous cell carcinoma and preneoplastic lesions. Lung Cancer. 2001;34:351-361.
23. Sanz-Ortega J, Saez MC, Sierra E, et al. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy. J Pathol. 2001;195:429-434.
24. Caballero OL, Cohen D, Liu Q, et al. Loss of chromosome arms 3p and 9p and inactivation of p16(INK4a) in normal epithelium of patients with primary lung cancer. Genes Chromosomes Cancer. 2001;32:119-125.
25. Hirsch FR, Franklin WA, Gazdar AF, et al. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res. 2001;7:5-22.
26. Park JY, Jeon HS, Park SH, et al. Microsatellite alteration in histologically normal lung tissue of patients with non-small cell lung cancer. Lung Cancer. 2000;30:83-89.
27. Field JK, Liloglou T, Xinarianos G, et al. Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer. Cancer Res. 1999;59:2690-2695.
28. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000;60:5954-5958.
29. INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A. 1998;95:11891-11896.
30. Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997;89:857-862.
31. Belinsky SA, Palmisano WA, Gilliland FD, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 2002;62:2370-2377.
32. Anttila S, Hakkola J, Tuominen P, et al. Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smoking. Cancer Res. 2003;63:8623-8628.
33. Thunnissen FB. Sputum examination for early detection of lung cancer. J Clin Pathol. 2003;56:805-810.